(FRPT) Freshpet - Ratings and Ratios
Dog Food, Cat Food, Dog Treats
FRPT EPS (Earnings per Share)
FRPT Revenue
Description: FRPT Freshpet
Freshpet Inc (NASDAQ:FRPT) is a leading manufacturer and distributor of natural fresh meals and treats for dogs and cats, operating primarily in the US, Canada, and Europe. The companys product portfolio includes dog food, cat food, and dog treats under the Freshpet brand, as well as fresh treats under the Dognation and Dog Joy brand names.
The companys unique distribution strategy involves a network of company-owned branded refrigerators, known as Freshpet Fridges, which are placed in various retail outlets, including grocery stores, mass retailers, club stores, pet specialty stores, and natural food stores, as well as online channels. This approach enables Freshpet to maintain control over the storage and display of its products, ensuring freshness and quality.
From a growth perspective, Freshpet has demonstrated an ability to expand its customer base and increase sales through its innovative distribution strategy and product offerings. Key performance indicators (KPIs) to monitor include revenue growth, gross margin expansion, and the rate of new fridge installations. Additionally, metrics such as customer acquisition costs, customer retention rates, and average order value can provide insights into the companys sales and marketing effectiveness.
To further evaluate Freshpets performance, its essential to analyze its financial statements and ratios. For instance, the companys high P/E ratio of 227.73 suggests that investors have high expectations for future growth. The forward P/E ratio of 72.99 indicates that analysts expect earnings to grow significantly in the coming year. Moreover, the companys Return on Equity (RoE) of 1.52% is relatively low, which may indicate that the company is investing heavily in growth initiatives. Other relevant KPIs include the companys gross margin ratio, operating expense ratio, and cash flow generation.
In terms of competitive positioning, Freshpet operates in the pet food industry, which is characterized by increasing demand for premium and natural products. The companys focus on fresh, natural ingredients and its unique distribution strategy differentiate it from competitors. To maintain its competitive edge, Freshpet must continue to innovate and expand its product offerings, while also investing in marketing and customer acquisition initiatives.
FRPT Stock Overview
| Market Cap in USD | 2,723m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | 2014-11-07 |
FRPT Stock Ratings
| Growth Rating | -58.3% |
| Fundamental | 55.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -67.2% |
| Analyst Rating | 4.37 of 5 |
FRPT Dividends
Currently no dividends paidFRPT Growth Ratios
| Growth Correlation 3m | -87.3% |
| Growth Correlation 12m | -84.4% |
| Growth Correlation 5y | -23.7% |
| CAGR 5y | -12.97% |
| CAGR/Max DD 5y | -0.16 |
| Sharpe Ratio 12m | -0.67 |
| Alpha | 0.00 |
| Beta | 0.987 |
| Volatility | 56.59% |
| Current Volume | 2702.3k |
| Average Volume 20d | 1168.4k |
| Stop Loss | 49.7 (-6.5%) |
| Signal | -2.60 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (33.7m TTM) > 0 and > 6% of Revenue (6% = 62.6m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 14.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.05% (prev 36.02%; Δ -4.97pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 145.2m > Net Income 33.7m (YES >=105%, WARN >=100%) |
| Net Debt (251.5m) to EBITDA (65.6m) ratio: 3.83 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (50.2m) change vs 12m ago 3.58% (target <= -2.0% for YES) |
| Gross Margin 40.79% (prev 35.66%; Δ 5.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 66.21% (prev 58.10%; Δ 8.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.69 (EBITDA TTM 65.6m / Interest Expense TTM 13.7m) >= 6 (WARN >= 3) |
Altman Z'' 0.33
| (A) 0.20 = (Total Current Assets 409.2m - Total Current Liabilities 85.0m) / Total Assets 1.65b |
| (B) -0.17 = Retained Earnings (Balance) -278.1m / Total Assets 1.65b |
| (C) 0.01 = EBIT TTM 23.1m / Avg Total Assets 1.58b |
| (D) -0.48 = Book Value of Equity -278.4m / Total Liabilities 575.8m |
| Total Rating: 0.33 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.37
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 2.09% = 1.04 |
| 3. FCF Margin 5.76% = 1.44 |
| 4. Debt/Equity 0.37 = 2.43 |
| 5. Debt/Ebitda 6.10 = -2.50 |
| 6. ROIC - WACC -6.96% = -8.69 |
| 7. RoE 3.21% = 0.27 |
| 8. Rev. Trend 98.12% = 4.91 |
| 9. Rev. CAGR 22.54% = 2.50 |
| 10. EPS Trend 59.20% = 1.48 |
| 11. EPS CAGR 47.11% = 2.50 |
What is the price of FRPT shares?
Over the past week, the price has changed by -7.54%, over one month by -24.09%, over three months by -34.66% and over the past year by -61.26%.
Is Freshpet a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FRPT is around 41.28 USD . This means that FRPT is currently overvalued and has a potential downside of -22.3%.
Is FRPT a buy, sell or hold?
- Strong Buy: 12
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FRPT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 88.7 | 66.9% |
| Analysts Target Price | 88.7 | 66.9% |
| ValueRay Target Price | 46.3 | -12.8% |
Last update: 2025-09-01 04:45
FRPT Fundamental Data Overview
CCE Cash And Equivalents = 243.7m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 84.5758
P/E Forward = 54.6448
P/S = 2.6081
P/B = 2.5408
P/EG = 1.4292
Beta = 1.77
Revenue TTM = 1.04b USD
EBIT TTM = 23.1m USD
EBITDA TTM = 65.6m USD
Long Term Debt = 396.2m USD (from longTermDebt, last quarter)
Short Term Debt = 4.29m USD (from shortTermDebt, last quarter)
Debt = 400.5m USD (Calculated: Short Term 4.29m + Long Term 396.2m)
Net Debt = 251.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.88b USD (2.72b + Debt 400.5m - CCE 243.7m)
Interest Coverage Ratio = 1.69 (Ebit TTM 23.1m / Interest Expense TTM 13.7m)
FCF Yield = 2.09% (FCF TTM 60.1m / Enterprise Value 2.88b)
FCF Margin = 5.76% (FCF TTM 60.1m / Revenue TTM 1.04b)
Net Margin = 3.23% (Net Income TTM 33.7m / Revenue TTM 1.04b)
Gross Margin = 40.79% ((Revenue TTM 1.04b - Cost of Revenue TTM 618.2m) / Revenue TTM)
Tobins Q-Ratio = -10.34 (set to none) (Enterprise Value 2.88b / Book Value Of Equity -278.4m)
Interest Expense / Debt = 0.94% (Interest Expense 3.75m / Debt 400.5m)
Taxrate = 1.26% (598.0k / 47.5m)
NOPAT = 22.8m (EBIT 23.1m * (1 - 1.26%))
Current Ratio = 4.81 (Total Current Assets 409.2m / Total Current Liabilities 85.0m)
Debt / Equity = 0.37 (Debt 400.5m / last Quarter total Stockholder Equity 1.07b)
Debt / EBITDA = 6.10 (Net Debt 251.5m / EBITDA 65.6m)
Debt / FCF = 6.66 (Debt 400.5m / FCF TTM 60.1m)
Total Stockholder Equity = 1.05b (last 4 quarters mean)
RoA = 2.04% (Net Income 33.7m, Total Assets 1.65b )
RoE = 3.21% (Net Income TTM 33.7m / Total Stockholder Equity 1.05b)
RoCE = 1.59% (Ebit 23.1m / (Equity 1.05b + L.T.Debt 396.2m))
RoIC = 1.58% (NOPAT 22.8m / Invested Capital 1.44b)
WACC = 8.53% (E(2.72b)/V(3.12b) * Re(9.65%)) + (D(400.5m)/V(3.12b) * Rd(0.94%) * (1-Tc(0.01)))
Shares Correlation 5-Years: 90.0 | Cagr: 3.71%
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.55% ; FCFE base≈60.1m ; Y1≈39.5m ; Y5≈18.0m
Fair Price DCF = 5.69 (DCF Value 277.4m / Shares Outstanding 48.8m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 98.12 | Revenue CAGR: 22.54%
Rev Growth-of-Growth: -9.11
EPS Correlation: 59.20 | EPS CAGR: 47.11%
EPS Growth-of-Growth: -81.28
Additional Sources for FRPT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle